home / stock / mbio / mbio news

MBIO News and Press, Mustang Bio Inc. From 06/11/20

Stock Information
Company Name: Mustang Bio Inc.
Stock Symbol: MBIO
Market: NASDAQ
Website: mustangbio.com
Menu
MBIO MBIO Quote MBIO Short MBIO News MBIO Articles MBIO Message Board
Get MBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
MBIO - GNUS, MBIO among premarket losers

TDH Holdings (NASDAQ: PETZ ) -35% . More news on: TDH Holdings, Inc., Genius Brands International, Inc., Hertz Global Holdings, Inc., Stocks on the move, Read more ...

MBIO - FCEL, HTZ, ASNA and MBIO among after-hours movers

Gainers:  JFIN +15% . FTSI +11.1% . JACK +8.4% . ASNA +6.4% . DUO +5.7% . More news on: Jiayin Group Inc., FTS International, Inc., Jack in the Box Inc., Stocks on the move, , Read more ...

MBIO - Mustang Bio to Host Virtual Annual Meeting of Stockholders

WORCESTER, Mass., June 04, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...

MBIO - LK, ALT, CLBS and BLRX among midday movers

Gainers:  Mmtec (NASDAQ: MTC )  +83% . More news on: Mmtec, Inc., Luckin Coffee Inc., Mitcham Industries, Inc., Stocks on the move, , Read more ...

MBIO - Mustang Bio Announces Presentations at 23rd Annual Meeting of the American Society of Gene & Cell Therapy

WORCESTER, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, soli...

MBIO - Mustang Bio EPS beats by $0.24

Mustang Bio (NASDAQ: MBIO ): Q1 Non-GAAP EPS of -$0.07 beats by $0.24 ; GAAP EPS of -$0.19 beats by $0.12 . More news on: Mustang Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MBIO - Mustang Bio Reports First Quarter 2020 Financial Results and Recent Corporate Highlights

WORCESTER, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, soli...
MBIO - Mustang Bio up 8% premarket on accelerated review status for MB-107 in Europe

The European Medicines Agency (EMA) has granted Advanced Therapy Medicinal Product (ATMP) classification to Mustang Bio's (NASDAQ: MBIO ) MB-107, a lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency, also known as bubble boy disease. More news on: Must...

MBIO - Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency

NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumo...

MBIO - Mustang Bio EPS misses by $0.15

Mustang Bio (NASDAQ: MBIO ): FY GAAP EPS of -$1.29 misses by $0.15 . More news on: Mustang Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10